| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Fiztasovimab | NPC-21 | Phase 2 Clinical | Nobelpharma Co Ltd | Cytomegalovirus Infections | Details |
| TRL-345 | CMV-345; TRL-345 | Phase 1 Clinical | Trellis Bioscience LLC | Cytomegalovirus Infections | Details |